300289 Stock Overview
Researches and developss, manufactures, and sells vitro diagnostic reagents and instruments, and biochemical raw materials in the People’s Republic of China. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Beijing Leadman Biochemistry Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥4.53 |
| 52 Week High | CN¥6.09 |
| 52 Week Low | CN¥3.45 |
| Beta | 0.048 |
| 1 Month Change | -21.63% |
| 3 Month Change | -4.63% |
| 1 Year Change | -23.74% |
| 3 Year Change | -51.39% |
| 5 Year Change | -22.03% |
| Change since IPO | -31.41% |
Recent News & Updates
Recent updates
Beijing Leadman Biochemistry Co.,Ltd.'s (SZSE:300289) 44% Price Boost Is Out Of Tune With Revenues
Oct 08
A Look At The Fair Value Of Beijing Leadman Biochemistry Co.,Ltd. (SZSE:300289)
Apr 19Beijing Leadman Biochemistry Co.,Ltd. (SZSE:300289) Shares Fly 27% But Investors Aren't Buying For Growth
Mar 08Shareholder Returns
| 300289 | CN Biotechs | CN Market | |
|---|---|---|---|
| 7D | -3.0% | -1.5% | -1.5% |
| 1Y | -23.7% | -22.7% | 5.6% |
Return vs Industry: 300289 underperformed the CN Biotechs industry which returned -22.7% over the past year.
Return vs Market: 300289 underperformed the CN Market which returned 5.6% over the past year.
Price Volatility
| 300289 volatility | |
|---|---|
| 300289 Average Weekly Movement | 6.2% |
| Biotechs Industry Average Movement | 6.2% |
| Market Average Movement | 7.2% |
| 10% most volatile stocks in CN Market | 11.2% |
| 10% least volatile stocks in CN Market | 4.4% |
Stable Share Price: 300289 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 300289's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1997 | 468 | n/a | www.leadmanbio.com |
Beijing Leadman Biochemistry Co.,Ltd. researches and developss, manufactures, and sells vitro diagnostic reagents and instruments, and biochemical raw materials in the People’s Republic of China. The company’s biochemical raw materials include enzymes, coenzymes, antibodies, buffers, enzyme substrates, culture mediums, stain reagents, amino acids, and other products primarily for biotechnology, clinical diagnosis, drug development, chemical production, and other related applications.
Beijing Leadman Biochemistry Co.,Ltd. Fundamentals Summary
| 300289 fundamental statistics | |
|---|---|
| Market cap | CN¥2.46b |
| Earnings (TTM) | -CN¥7.36m |
| Revenue (TTM) | CN¥403.24m |
6.1x
P/S Ratio-334.9x
P/E RatioIs 300289 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 300289 income statement (TTM) | |
|---|---|
| Revenue | CN¥403.24m |
| Cost of Revenue | CN¥178.91m |
| Gross Profit | CN¥224.32m |
| Other Expenses | CN¥231.68m |
| Earnings | -CN¥7.36m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Mar 28, 2025
| Earnings per share (EPS) | -0.014 |
| Gross Margin | 55.63% |
| Net Profit Margin | -1.82% |
| Debt/Equity Ratio | 0% |
How did 300289 perform over the long term?
See historical performance and comparisonDividends
0.2%
Current Dividend Yield-69%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/10 19:24 |
| End of Day Share Price | 2025/01/10 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Beijing Leadman Biochemistry Co.,Ltd. is covered by 14 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Shuchang Liu | Changjiang Securities Co. LTD. |
| Shanshan Li | China Merchants Securities Co. Ltd. |
| Tong Zhang | China Merchants Securities Co. Ltd. |